| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Canada | 5 | |
| #2 | United States | 2 | |
| #3 | WIPO (World Intellectual Property Organization) | 2 | |
| #4 | Australia | 1 | |
| #5 | EPO (European Patent Office) | 1 | |
| #6 | Hong Kong | 1 | |
| #7 | Mexico | 1 | |
| #8 | New Zealand | 1 | |
| #9 | Taiwan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Environmental technology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Medical preparations | |
| #2 | Therapeutic chemical compounds | |
| #3 | Climate change adaptation technologies | |
| #4 | Analysing materials |
| # | Name | Total Patents |
|---|---|---|
| #1 | Buchanan Michael R | 11 |
| #2 | Horrobin David | 11 |
| #3 | Buchanan Michael | 3 |
| Publication | Filing date | Title |
|---|---|---|
| CA2381613A1 | Cardiovascular disease and thrombotic risk diagnostic tests | |
| CA2481114A1 | Cardiovascular disease and thrombotic risk diagnostic tests | |
| CA2344007A1 | Cardiovascular disease and thrombotic risk diagnostic tests | |
| CA2403566A1 | Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia | |
| CA2304906A1 | 13-hode, a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |